C

Cox Health | Wheeler Heart And Vascular Center

Research site
(Unclaimed)
Location
3800 S. National Ave Suite 540, Springfield, Missouri, United States of America

Site insights

Top conditions

Top treatments

Platinum
Paclitaxel
Cilastatin
Cilastatin-XNW4107
Milvexian
Imipenem
XNW4107-302
Relebactam

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 15 total trials

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.

Enrolling
Ischemic Stroke; Ischemic Attack, Transient
Drug: Placebo
Drug: Milvexian

This study aims to compare treatment with Imipenem/Cilastatin-XNW4107 (IMI-XNW4107) with imipenem/cilastatin/relebactam (IMI/REL) in participants wit...

Enrolling
Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia
Drug: Combination of Imipenem/Cilastatin and XNW4107
Drug: Imipenem/Cilastatin/Relebactam

This trial is being conducted to evaluate the efficacy of Phasix™ Mesh implantation at the time of midline fascial closure compared to primary suture...

Enrolling
Open Midline Laparotomy
Device: Phasix™ Mesh

Trial sponsors

Boston Scientific logo
A
C
E
J
Yale University logo
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems